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Malta imports 99% of the medicinal preparations for local consumption 
and the vast majority of these are imported in the finished state. The 
problem of inflation emphasizes the necessity of examining our imports, 
since these incur a heavy drain on our foreign resources. As regards 
medicines, the most important key indicators that determine their rate 
and character of consumption by the consumer are: 
a ) population size; 
b) age structure; and 
c) health care expectations of the consumers 
The aims of this study were to: 
a) work out a trend of the expenditure on medicinal and 
pharmaceutical products by the Maltese consumers during the 
period 1981 and 1990; and 
b) to determine the reasons leading to such a trend, if any. 
Methodology 
Study 1 
A statistical review of the expenditure on medicinal and ,pharmaceutical 
products by the consumers for the ten year period 1981-1990 was worked 
out. Data was collected from the Central Office of Statistics, Valletta. 
Study 2 
Two surveys were conducted -
. Survey A involved 2 groups of Maltese consumers in the age group of 30-60 
years and coming from different regions of Malta. Group 1 included 100 
university graduates in professions other than the medical profession and 
group 2 included 100 members of the community none of which specialized 
in any profession. The questionnaire was set in Maltese. The aim of this 
questionnaire was mainly to determine the consumers' knowledge and 
attitude about the price quality relationship of medicines. 
Survey B was distributed to 150 community pharmacists. Questions were 
asked about -
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a) consumption of medicines by the population according to age group; 
b) the change in the number of drugs per prescription as prescribed by 
doctors, over the past decade; 
c) the percentage of prescriptions with generic drug names; 
d) the percentage of consumers who claim to know about the presence 
of generic and patented drugs; and 
e) whether they informed consumers about this subject. 
Results 
Study 1 
The expenditure on medicinal and pharmaceutical products by the 
Maltese consumer, over the ten year period 1981-1990, was 
calculated. It was found that the expenditure for the year 1990 was Lm14 
million, the highest ever, as compared to Lm12.5 million in the year 
1989. The lowest expenditure (Lm6.5 million) was in the year 1981. 
Study 2 
Survey A: 51 % from group 1 and 33% from group 2 answered the 
questionnaire. Results are shown below: 
a. know about the presence of generic and 
patent drugs on the market 
b. with to be consulted by the doctor or 
pharmacist about the different costs 
of a generic and a patented drug 
c. bought prescription medicines with a 
prescription 
d. did not agree that pharmacists should 
be authorized to dispense certain 
prescription medicines with a prescription 
e. keep remaining medicines for re-use 
following a course of treatment 
f. would buy the generic (cheaper) product 
g. would buy a locally manufactured 
medicinal product 
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Group 1 
(%) 
46 
72 
62 
61 
78 
76 
50 
Group 2 
(%) 
51 
75 
56 
60 
56 
72 
34 
SurveyB 
The replies totalled 43. The age group 0-14 years is considered to consume 
medicines by 72% of the pharmacists who answered the questionnaire. 
87% believed that the number of drugs prescribed per prescription has 
increased over the past decade, as has also the consumption of over the 
counter (OTC) products. As regards generic drugs, all respondents a=said 
that generic prescribing is low in Malta (about 7%) as compared with 
prescribing of branded products. 88% of pharmacists consider that the 
percentage of consumers knowing about the presence of generic and 
patented drugs, ranges from 0-25% .. The percentage of pharmacists that 
give information about this fact totalled 81 %. 
Discussion 
During the period 1981-1990 the expenditure by the Maltese consumer on 
medicinal and pharmaceutical products, increased by 118% while the 
population increased by 11 %. The increase in the age group 0-14 years 
was of 13%; the age group 15-29 years decreased by 22%; and the age 
groups 30-59 and 60 years onwards (Le. the elderly population) increased 
by 70% and 39% respectively. 
This shows that age structure is gradually shifting towards the pattern 
of longevity of life and also towards an aging population. Most elderly 
patients have chronic conditions that are prevalent in Malta, such as 
diabetes and hypertension. This entitles them for free medication by the 
National Health Service and thus reduces their consumption from 
community pharmacies. In fact survey B showed that the youngest age 
group consume most of the medicines, even thouh there was an increase 
for the elderly population. The age group 30-59 years was the most to 
increase in population, however. 
Therefore the reasons for such an increase in the expenditure on medicinal 
and pharmaceutical products are: 
a) the increased health care expectations and awareness by the 
population. This reflected through: 
i) a high consumption of medicinal preparations by the age 
group 0-14 years; 
i i) an increased consumption of OTe products; 
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iii) an increase in the number of drugs per prescription as 
prescribed by general practitioners; 
b) the high percentage of prescriptions for patented drugs (between 90 
and 95% of prescriptions); 
c) an increase in the cost of medicines as shown by an increase of the 
retail price index. 
The responses given by the two groups of consumers in Survey A compare 
quite well, in spite of the difference in their occupational states. There is 
awareness among the consumers about their increased expenditure on 
medicines. This is evidenced by the consumers' choice for a generic 
instead of a patented product (an average of 74% of those who 
responded); and also by the fact that 75% (average) wished to be 
consulted about the various costs of a medicine. 
Consumption of prescription medicines without the necessary prescription 
by an average of 60% consumers from both groups, may also reflect this 
awareness through the avoidance of the doctor's fee. However another 
60% of the respondents did not agree that a pharmacist should dispense 
certain prescription medicines without a doctor's prescription. 
Knowledge about the presence of generic products is quite low among 
c-msumers. The confidence in a locally manufactured medicinal produ..:t is 
also low, especially by group 2 consumers. 
Conclusion 
It is beneficial both for the health of our population and for our economy 
that: 
a) polypharmacy is reduced; 
b) generic prescribing by doctors is enhanced; 
c) the consumer is given more information about the subject of generic 
drug products and about a proper consumption of OTC products. 
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The establishing of better Quality Control facilities, both for locally 
manufactured and imported pharmaceuticals, will enhance the 
confidence among consumers towards buying good quality generic drugs. 
This will even stimulate the expansion of the local. pharmaceutical 
industry which would then have more consumers. 
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